The Role of Gender Transformative Interventions to Strengthen Gender Equity and Improve Immunization Outcomes
NCT ID: NCT06258200
Last Updated: 2025-09-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
448 participants
INTERVENTIONAL
2024-09-09
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants (male and female caregivers of children under 12 months of age) will be sorted into intervention or comparison groups based on their community of residence. Participants in the intervention group will:
* Receive household visits to raise awareness of immunization benefits and gender equity
* Participate in couples communication discussion groups
* Receive immunization and gender equity messaging from community leaders and other influencers.
Researchers will compare the intervention group with comparison groups in similar communities to see if the intervention group demonstrates improved equitable gender relations and increased rates of immunization compared to the comparison group which does not receive the intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact Assessment of the Rural Response System to Reduce Violence Against Women in Ghana
NCT03237585
Effect of Formal Letter of Invitation on Male Partner Involvement at Antenatal Care Clinic
NCT06171503
A Hybrid Effectiveness/Implementation Trial of the International Guide for Monitoring Child Development
NCT04665297
Testing Gender-based Violence Response in Family Planning and Antenatal Care Services in Nigeria
NCT05331508
Integrated Community Based Health Systems Strengthening in Northern Togo
NCT03694366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Participants in this arm will receive behavioral interventions, including household visits, participation in couples discussion groups, and messaging from community leaders.
Gender and immunization activities
Household visits from community mobilizers, participation in couples communication groups, and messaging from community leaders.
Comparison
Participants in this arm will not receive any interventions.
No intervention
Participants in the comparison group will not receive any intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gender and immunization activities
Household visits from community mobilizers, participation in couples communication groups, and messaging from community leaders.
No intervention
Participants in the comparison group will not receive any intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult women and men aged 18-49 who are in a monogamous relationship, or polygamous relationship in which the male partner agrees to participate with one female partner, and are together caregivers of at least one child 12 months of age or younger
* Have lived in the study site for at least one year
* Plan to continue to live in the study site for at least one year from time of recruitment
* If the caregiver is drawn from one of the intervention Union Councils, must be willing to fully participated in the intervention for the full implementation period
Caregivers Togo:
* Adult women and men aged 18-49 who are in a monogamous relationship, or are in a polygamous relationship in which the man resides only with the woman who is also involved in the study, and who and are together caregivers of at least one child 12 months of age or younger
* Have lived in the study site for at least one year
* Plan to continue to live in the study site for at least one year from time of recruitment
* If the caregiver is drawn from one of the intervention communities, must be willing to fully participate in the intervention for the full implementation period
Community mobilizers Pakistan:
* A woman or man currently living in the intervention Union Councils
* Has at least one child who has received the complete vaccine series
* Fluently speak the language that is most commonly spoken in the Union Council in which they live
* Be able to read and write
* Have previous experience of working on advocacy and community mobilization
* Have previously worked on childhood immunization mobilization
* Are familiar with the community influencers
* Are willing to complete training for the intervention
* Must be willing to actively implement intervention for the full implementation period
Papas Champions Togo:
* Be a married man with children, who has demonstrated his involvement in his children's health
* Has at least one child who has received the complete vaccine series
* Currently live in the intervention community
* Fluently speak the language that is most commonly spoken in the community in which they live
* Be able to read and write
* Be willing to promote the benefits of vaccination to other fathers in the community
* Be willing to work on a voluntary basis\*
* Be accepted by the local community and recognized as a responsible and respectable person.
* Be willing to complete training for the intervention
* Be willing to actively implement the intervention for the full implementation period
CSO Leaders Pakistan:
* Be based in one of the intervention Union Councils
* Actively support implementation intervention
CSO Leaders Togo:
* Be based in one of the intervention districts
* Actively support implementation intervention
Community Leaders Pakistan:
* Be based in one of the intervention Union Councils
* Have known influence on gender dynamics, caregiving, and child health behaviors including immunization
* Be willing to participate in the values clarification and attitudinal transformation activities conducted as part of the intervention
Community Leaders Togo:
* Be based in one of the intervention communities
* Have known influence on gender dynamics, caregiving, and child health behaviors including immunization
* Be willing to participate in the community sensitization activities conducted as part of the intervention
EPI Stakeholders Pakistan/Togo:
* Be based in one of the study districts since the beginning of the study
* Be familiar with the operations research intervention conducted as part of the study
18 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gavi, The Vaccine Alliance
OTHER
Jhpiego
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elaine Charurat
Role: STUDY_DIRECTOR
Jhpiego
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Community Setting
Uc-10 Pehalwan Goth - Gulshan Town, Karachi East, Pakistan
Community Setting
Uc-11 Garden East - Jamshed Town, Karachi East, Pakistan
Community Setting
UC 10/B, Quetta, Pakistan
Community Setting
UC 13/A, Quetta, Pakistan
Community Setting
Adakpamé, Golfe, Togo
Community Setting
Adamavo, Golfe, Togo
Community Setting
Kanyikope, Golfe, Togo
Community Setting
Ségbé, Golfe, Togo
Community Setting
Gbodjome / Kpogan Agbetiko, Lacs, Togo
Community Setting
Gbodjome /agbataloglo, Lacs, Togo
Community Setting
Moretan /assati, Mono-Est, Togo
Community Setting
Kpekpleme/ Kativou, Moyen-mono, Togo
Community Setting
TADO /tado DOME, Moyen-mono, Togo
Community Setting
Dagbati, Vo, Togo
Community Setting
Dzrekpo /klologo, Vo, Togo
Community Setting
Ahépé, Yoto, Togo
Community Setting
Kouvé, Yoto, Togo
Community Setting
Abobo / LEBE, Zio, Togo
Community Setting
Mission TOVE / Apessito, Zio, Togo
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00027395
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.